A gene-environment interaction between occupation and BRCA1|BRCA2 mutations in male breast cancer?

被引:27
作者
Palli, D
Masala, G
Mariani-Costantini, R
Zanna, I
Saieva, C
Sera, F
Decarli, A
Ottini, L
机构
[1] Sci Inst Tuscany, CSPO, Mol & Nutr Epidemiol Unit, I-50135 Florence, Italy
[2] Univ Gabriele Dannunzio, Dept Oncol & Neurosci, Chieti, Italy
[3] Univ Brescia, Med Stat & Biometry Sect, Brescia, Italy
[4] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
关键词
male breast cancer; BRCA1; BRCA2; occupation; gene-environment interaction; polycyclic aromatic hydrocarbons;
D O I
10.1016/j.ejca.2004.07.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The association of male breast cancer (MBC) with a positive breast cancer (BC) family history and with BRCA1/2 germ-line mutations points to a genetic component; a relationship with occupation has also been reported. Recently, we identified pathogenetic BRCA1/2 mutations in a population-based series of Italian MBC patients: here in, we investigated interactions between a carrier status for BRCA1/2 mutations and occupation using a case-case design and estimating case-only odds ratios (CORs). Truck-driving was the most frequent occupation (3/4 BRCA-related cases and 2/19 unrelated cases). An interaction between carrier status and working as a truck-driver emerged, when we classified MBC cases as "ever/never-held" this job title (COR 25.5; 95% Confidence Limits (CL): 1.1-1,412.5) or according to truck-driving as the "longest-held" work (COR 54.0; 95% CL: 1.62,997.5). The possible modifying effect on MBC risk in subjects carrying BRCA1/2 germ-line mutations of an occupation characterised by exposure to chemicals such as polycyclic aromatic hydrocarbons (PAH) that are capable of inducing DNA damage, may provide clues to the role of environmental exposures in modifying BC risk in mutation carriers in both genders. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2474 / 2479
页数:6
相关论文
共 36 条
[1]   Identification of occupational cancer risks in British Columbia - A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors [J].
Band, PR ;
Le, ND ;
Fang, R ;
Deschamps, M ;
Gallagher, RP ;
Yang, P .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2000, 42 (03) :284-310
[2]   Case-control study of occupational exposures and male breast cancer [J].
Cocco, P ;
Figgs, L ;
Dosemeci, M ;
Hayes, R ;
Linet, MS ;
Hsing, AW .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1998, 55 (09) :599-604
[3]   MORTALITY AMONG URBAN POLICEMEN IN ROME [J].
FORASTIERE, F ;
PERUCCI, CA ;
DIPIETRO, A ;
MICELI, M ;
RAPITI, E ;
BARGAGLI, A ;
BORGIA, P .
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1994, 26 (06) :785-798
[4]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[5]  
Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P677
[6]   Smoking and the risk of breast cancer among carriers of BRCA mutations [J].
Ghadirian, P ;
Lubinski, J ;
Lynch, H ;
Neuhausen, SL ;
Weber, B ;
Isaacs, C ;
Baruch, RG ;
Randall, S ;
Ainsworth, P ;
Freidman, E ;
Horsman, D ;
Tonin, P ;
Foulkes, WD ;
Tung, N ;
Sun, P ;
Narod, SA .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (03) :413-416
[7]  
Hansen J, 2000, AM J IND MED, V37, P349, DOI 10.1002/(SICI)1097-0274(200004)37:4<349::AID-AJIM4>3.3.CO
[8]  
2-C
[9]   Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as risk factors [J].
Jeffy, BD ;
Chirnomas, RB ;
Romagnolo, DF .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2002, 39 (2-3) :235-244
[10]  
Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207